528 related articles for article (PubMed ID: 27882487)
1. Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer.
Yang T; Fogarty B; LaForge B; Aziz S; Pham T; Lai L; Bai S
AAPS J; 2017 Mar; 19(2):475-486. PubMed ID: 27882487
[TBL] [Abstract][Full Text] [Related]
2. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio.
Yang T; Martin P; Fogarty B; Brown A; Schurman K; Phipps R; Yin VP; Lockman P; Bai S
Pharm Res; 2015 Jun; 32(6):2003-14. PubMed ID: 25609010
[TBL] [Abstract][Full Text] [Related]
3. Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21/VEGF signal.
Sun X; Ma X; Wang J; Zhao Y; Wang Y; Bihl JC; Chen Y; Jiang C
Oncotarget; 2017 May; 8(22):36137-36148. PubMed ID: 28410224
[TBL] [Abstract][Full Text] [Related]
4. Milk exosomes - Natural nanoparticles for siRNA delivery.
Aqil F; Munagala R; Jeyabalan J; Agrawal AK; Kyakulaga AH; Wilcher SA; Gupta RC
Cancer Lett; 2019 May; 449():186-195. PubMed ID: 30771430
[TBL] [Abstract][Full Text] [Related]
5. Transmigration of Tetraspanin 2 (Tspan2) siRNA Via Microglia Derived Exosomes across the Blood Brain Barrier Modifies the Production of Immune Mediators by Microglia Cells.
Reynolds JL; Mahajan SD
J Neuroimmune Pharmacol; 2020 Sep; 15(3):554-563. PubMed ID: 31823250
[TBL] [Abstract][Full Text] [Related]
6. Exosome-Modified Tissue Engineered Blood Vessel for Endothelial Progenitor Cell Capture and Targeted siRNA Delivery.
Chen W; Yang M; Bai J; Li X; Kong X; Gao Y; Bi L; Xiao L; Shi B
Macromol Biosci; 2018 Feb; 18(2):. PubMed ID: 29205878
[TBL] [Abstract][Full Text] [Related]
7. Cluster of Differentiation 46 Is the Major Receptor in Human Blood-Brain Barrier Endothelial Cells for Uptake of Exosomes Derived from Brain-Metastatic Melanoma Cells (SK-Mel-28).
Kuroda H; Tachikawa M; Yagi Y; Umetsu M; Nurdin A; Miyauchi E; Watanabe M; Uchida Y; Terasaki T
Mol Pharm; 2019 Jan; 16(1):292-304. PubMed ID: 30452273
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of optimized liposomes for delivery of small interfering RNA.
Yang T; Bantegui T; Pike K; Bloom R; Phipps R; Bai S
J Liposome Res; 2014 Dec; 24(4):270-9. PubMed ID: 24708056
[TBL] [Abstract][Full Text] [Related]
9. Exosomes are natural carriers of exogenous siRNA to human cells in vitro.
Shtam TA; Kovalev RA; Varfolomeeva EY; Makarov EM; Kil YV; Filatov MV
Cell Commun Signal; 2013 Nov; 11():88. PubMed ID: 24245560
[TBL] [Abstract][Full Text] [Related]
10. RNAi delivery by exosome-mimetic nanovesicles - Implications for targeting c-Myc in cancer.
Lunavat TR; Jang SC; Nilsson L; Park HT; Repiska G; Lässer C; Nilsson JA; Gho YS; Lötvall J
Biomaterials; 2016 Sep; 102():231-8. PubMed ID: 27344366
[TBL] [Abstract][Full Text] [Related]
11. Hypoxic glioblastoma release exosomal VEGF-A induce the permeability of blood-brain barrier.
Zhao C; Wang H; Xiong C; Liu Y
Biochem Biophys Res Commun; 2018 Jul; 502(3):324-331. PubMed ID: 29787762
[TBL] [Abstract][Full Text] [Related]
12. Exosome-mediated delivery of siRNA in vitro and in vivo.
El-Andaloussi S; Lee Y; Lakhal-Littleton S; Li J; Seow Y; Gardiner C; Alvarez-Erviti L; Sargent IL; Wood MJ
Nat Protoc; 2012 Dec; 7(12):2112-26. PubMed ID: 23154783
[TBL] [Abstract][Full Text] [Related]
13. Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes.
Wahlgren J; De L Karlson T; Brisslert M; Vaziri Sani F; Telemo E; Sunnerhagen P; Valadi H
Nucleic Acids Res; 2012 Sep; 40(17):e130. PubMed ID: 22618874
[TBL] [Abstract][Full Text] [Related]
14. Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles.
Wei L; Guo XY; Yang T; Yu MZ; Chen DW; Wang JC
Int J Pharm; 2016 Aug; 510(1):394-405. PubMed ID: 27374198
[TBL] [Abstract][Full Text] [Related]
15. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
16. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
[TBL] [Abstract][Full Text] [Related]
17. Exosomes from iPSCs Delivering siRNA Attenuate Intracellular Adhesion Molecule-1 Expression and Neutrophils Adhesion in Pulmonary Microvascular Endothelial Cells.
Ju Z; Ma J; Wang C; Yu J; Qiao Y; Hei F
Inflammation; 2017 Apr; 40(2):486-496. PubMed ID: 28000095
[TBL] [Abstract][Full Text] [Related]
18. Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation.
Nazarenko I; Rana S; Baumann A; McAlear J; Hellwig A; Trendelenburg M; Lochnit G; Preissner KT; Zöller M
Cancer Res; 2010 Feb; 70(4):1668-78. PubMed ID: 20124479
[TBL] [Abstract][Full Text] [Related]
19. Delivering siRNA and Chemotherapeutic Molecules Across BBB and BTB for Intracranial Glioblastoma Therapy.
Yang ZZ; Gao W; Liu YJ; Pang N; Qi XR
Mol Pharm; 2017 Apr; 14(4):1012-1022. PubMed ID: 28252970
[TBL] [Abstract][Full Text] [Related]
20. A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery.
Zou Y; Guo CG; Yang ZG; Sun JH; Zhang MM; Fu CY
Drug Des Devel Ther; 2016; 10():1243-55. PubMed ID: 27069355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
